BMRN earnings date and history (2026)
BioMarin Pharmaceutical Inc. (BMRN) next reports earnings on Mon Oct 26. Analysts expect EPS of $1.13 (7 estimates), against -$0.08 in the same quarter a year ago. Last time, on Thu Aug 6, it reported $0.90 against a $0.79 consensus (+13.9%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.79 | $0.90 | — |
| May 4, 2026 | $0.78 | $0.58 | — |
| Feb 23, 2026 | $0.07 | $0.28 | — |
| Oct 27, 2025 | $0.82 | -$0.08 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does BMRN report earnings?
- BMRN is scheduled to report on Mon Oct 26, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from BMRN?
- The consensus estimate is $1.13 a share across 7 analysts; the same quarter a year ago came in at -$0.08.
- Did BMRN beat earnings last quarter?
- Yes: on Thu Aug 6 BMRN reported $0.90 against a $0.79 consensus, a +13.9% surprise.